— Will Provide Vital Information on Chronic Hepatitis B,

a Potentially Life-Threatening Liver Disease Affecting 2 Million Americans —

 — Site Contains Innovative Video Content, Multilingual Patient Materials —

 WHAT:           A new health education website,, sponsored by Gilead Sciences, Inc., intended for audiences in the United States, is launching Friday, September 7. contains practical information about chronic hepatitis B (CHB), a potentially life-threatening liver disease that affects an estimated two million people in the United States and is the leading cause of liver cancer.

Chronic hepatitis B is caused by a virus and can slowly damage the liver, without causing obvious symptoms.  Chronic hepatitis B can be diagnosed with a simple blood test, prevented with a vaccine, and managed with appropriate care – but alarmingly, most people living with the disease don’t know they are infected.

Without treatment, 1 in 4 people with CHB may die of disease-related complications. The impact of chronic hepatitis B in the United States is more severe among Asian American communities. features:

  • Information on how to prevent CHB, testing for the disease, and management of CHB.
  • An innovative animated video depicting a CHB patient’s journey from diagnosis to care (available in 14 languages with subtitles).
  • Educational brochures in 14 languages, including Chinese, Korean, Vietnamese, and Tagalog among others. is an educational website created by Gilead Sciences, a maker of medicines for chronic hepatitis B.  The website is part of Gilead’s ongoing effort to raise community awareness of chronic hepatitis B.

 WHEN:           Website live September 7.


 CONTACT:    Erwin Falcon (646-747-6777), APartnership, Inc.